KemPharm Inc

NASDAQ:KMPH 4:00:00 PM EDT

4.48

-0.04 (-0.88%)

5:06:00 PM EDT: $4.55 +0.07 (+1.56%)

Market Cap (Intraday)	154.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.11 Million
Adjusted EPS	-$0.19

See more estimates

10-Day MA	$4.66
50-Day MA	$5.34
200-Day MA	$5.19

See more pivots

KemPharm Inc Stock, NASDAQ:KMPH

1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747

United States of America

Phone: +1.321.939.3416

Number of Employees: 24

http://www.kempharm.com

Description

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.